Aug. 17, 2020 – The Federal Trade Commission (FTC) recently issued 20 Warning Letters to companies making coronavirus claims for such products as zappers that use certain frequencies to kill viruses or remove pathogens from the body, virus-busting cards to hang around the collar, ozone therapies – including “intravenous ozone” – nasal sprays, and elderberry […]
Read more
March 23, 2020 – As the United States grapples with the COVID-19 outbreak and its ongoing fallout, there is another pressing issue that is crucial to the American public: ensuring safe and fair elections between now and Nov. 3. “The Coalition believes it is important for all Americans to be active in the political process […]
Read more
Feb. 19, 2019 – In a move that “merits industry attention,” the Federal Trade Commission (FTC) announced last week that it had joined the Food and Drug Administration (FDA) in enforcement actions against three companies advertising that their products can treat diseases like Alzheimer’s, according to a Feb. 11 post by Lesley Fair, senior attorney, […]
Read more
By Michael Parenti, Senior Engagement Strategist, Saatchi & Saatchi Wellness Feb. 1, 2019 — On Oct. 25, 2018, the Centers for Medicare and Medicaid Services (CMS) issued an advance notice of proposed rulemaking (ANPRM) to test whether phasing down the Medicare payment amount for selected Part B drugs to more closely align with international prices […]
Read more
Jan. 3, 2019 – As healthcare communicators start off 2019, keeping an eye on the best ways to remain compliant is now a bit easier thanks to James N. Czaban, chair of the FDA and Medical Products Regulatory Practice at DLA Piper LLP in Washington, D.C. Speaking at the Coalition for Healthcare Communication’s Post-election Conference […]
Read more Feb. 20, 2018 – In President Donald J. Trump’s FY 2019 Budget, drug pricing is one of the top priorities for the Department of Health and Human Services (HHS), according to HHS Secretary Alex Azar. “The President’s budget makes investments and reforms that are vital to making our health and human services programs work for […]
Read more
Jan. 8, 2018 – The New Jersey ban on “gifts” from the pharmaceutical industry, an administrative action finalized on Dec. 22, 2017, will go into effect on Jan. 15 of this year and will be “the first of its kind for any state” to link compliance with physician licensure and apply to physicians, not the […]
Read more July 31, 2017 — Guest commentary by Michael Parenti America’s opioid crisis is a major issue and the subject of ongoing debate. But before we can begin to tackle this problem, we need to take a look at the policy decisions that got us here. War has a way of embedding itself within the public consciousness. […]
Read more Commentary from Jack Angel, Coalition for Healthcare Communication Education Foundation Executive Director Oct. 25, 2016 – The Coalition for Healthcare Communication is dedicated to monitoring and resisting efforts by any organization, including our government, to restrict the free flow of truthful, scientific information. It is a fact that a great deal of scientific information flows […]
Read moreOct. 17, 2016 – In a recent guest commentary in PM360, Coalition for Healthcare Communication Executive Director John Kamp praised Pfizer for its opioid agreement with the City of Chicago and called on the pharmaceuticals industry to engage now in the fight to help stem the tide of opioid addiction. In the PM360 piece, “In […]
Read more